Trial intelligence / Profile preview

Comparison of transanal irrigation and glycerol suppository in treatment of Low Anterior Resection Syndrome

2019-001913-17Phase 3Active

Sponsor
Aarhus University Hospital
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of glycerol in low anterior resection syndrome (LARS) (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Improvement of main symptom (MYMOP score). Started May 2019; status: active.

02

Drugs

glycerol
03

Conditions

low anterior resection syndrome (LARS)

Beyond the preview

Go deeper on 2019-001913-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-001913-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call